Neurogene OverviewNeurogene's common stock is $0.
Get informed when a big investor buys or sells
+ Follow
Latest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.
Neurogene (NGNE) currently reports a common stock of $0 as of June 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Neurogene's common stock history and peer comparisons.
Neurogene's common stock changed from $0 to $0 (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Neurogene reported $0 in common stock as of June 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current common stock of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Neurogene, and consider following NGNE for alerts when major investors trade the stock.
Neurogene is classified in the Healthcare sector. On common stock, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing NGNE with unrelated industries.
